CONCERT'S CNS THERAPEUTICS

concerts-cns-therapeutics-logo

Concert's CNS therapeutics offers compound that help in therapeutics across several different psychiatric and neurological conditions.

#SimilarOrganizations #More

CONCERT'S CNS THERAPEUTICS

Industry:
Health Care Medical Pharmaceutical

Status:
Active


Similar Organizations

acuity-pharmaceuticals-logo

Acuity Pharmaceuticals

Acuity Pharmaceuticals product-focused ophthalmic pharmaceutical company applying its proprietary technology to the treatment.

double-wood-logo

Double wood

Double wood is providing high-quality dietary supplements and keeping you in the know about industry-related news and research.

More informations about "Concert's CNS therapeutics"

Concert's CNS therapeutics - Crunchbase Company Profile

Mar 11, 2022 Organization. Concert's CNS therapeutics . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. Concert's CNS therapeutics offers โ€ฆSee details»

Terran Biosciences announces acquisition of a portfolio of novel โ€ฆ

Mar 11, 2022 Terran plans to quickly accelerate the development of these compounds as important complements to a growing pipeline of both early-stage and late-stage therapeutics โ€ฆSee details»

Concert's CNS therapeutics acquired by Terran Biosciences

Mar 11, 2022 Concert's CNS therapeutics Concert's CNS therapeutics offers compound that help in therapeutics across several different psychiatric and neurological conditions. Acquiring โ€ฆSee details»

Terran Biosciences announces acquisition of a portfolio of novel โ€ฆ

NEW YORK, March 11, 2022 /PRNewswire/ -- Terran Biosciences (โ€œTerranโ€), a biotech platform company dedicated to the development of transformational therapeutics for neurological and โ€ฆSee details»

Terran Biosciences Acquires Novel CNS Therapeutics from Concert ...

Mar 14, 2022 Terran plans to quickly accelerate the development of these compounds as important complements to a growing pipeline of both early-stage and late-stage therapeutics โ€ฆSee details»

Terran Biosciences announces acquisition of a portfolio of novel โ€ฆ

NEW YORK, March 11, 2022 /PRNewswire/ -- Terran Biosciences announces acquisition of a portfolio of novel CNS therapeutics from Concert PharmaceuticalsSee details»

Terran Biosciences announces acquisition of a portfolio of novel โ€ฆ

Mar 11, 2022 /PRNewswire/ -- Terran Biosciences ("Terran"), a biotech platform company dedicated to the development of transformational therapeutics for neurological and...See details»

Concert's CNS therapeutics - Crunchbase

Concert's CNS therapeutics offers compound that help in therapeutics across several different psychiatric and neurological conditions. Search Crunchbase. Start Free Trial . Chrome โ€ฆSee details»

Concert Pharmaceuticals /Central Nervous System Therapeutics/

Jul 30, 2023 Explore Concert Pharmaceuticals /Central Nervous System Therapeutics/ with its drug pipeline, therapeutic area, technology platform, .See details»

Terran Biosciences announces acquisition of a portfolio of novel โ€ฆ

NEW YORK, March 11, 2022 /PRNewswire/ โ€” Terran Biosciences (โ€œTerranโ€), a biotech platform company dedicated to the development of transformational therapeutics for neurological and โ€ฆSee details»

KOLM THERAPEUTICS INC. in Woodbridge, CT - Bizapedia

3 days ago KOLM THERAPEUTICS INC. is a Connecticut Foreign Stock filed on May 2, 2023. The company's filing status is listed as Active and its File Number is 2779885. The Registered โ€ฆSee details»

PTC Therapeutics Enters into a Global License and Collaboration ...

2 days ago - PTC to receive $1.0B in cash at closing - - PTC is eligible to receive up to $1.9B in development, regulatory and sales milestones - - PTC to share profits in the U.S. and tiered โ€ฆSee details»

Terran Biosciences - Funding, Financials, Valuation & Investors

Jan 1, 2022 Which types of acquisition does this organization make most frequently? Show . Acquiree Name . Announced Date . Price . Transaction Name . Concert's CNS therapeutics . โ€ฆSee details»

Cognition Therapeuticsโ€™ Analysis Correlates Biomarker ... - Nasdaq

Nov 25, 2024 --Cognition Therapeutics, Inc.,, a clinical-stage company developing drugs to treat neurodegenerative disorders, provided an update on a biomarker 1 analysis from the Phase 2โ€˜ โ€ฆSee details»

Stoke Therapeutics Receives FDA Breakthrough Therapy โ€ฆ

10 hours ago BEDFORD, Mass., December 04, 2024--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the โ€ฆSee details»

Manassas Low Testosterone Therapy Treatment for Men

Hormone Therapeutics aims to provide individualized care and provide the best treatment plan tailored for you. Your complete treatment plan will cost $199 a month, and will include medical โ€ฆSee details»

Terran Biosciences announces acquisition of a portfolio of novel โ€ฆ

(Adnkronos) - NEW YORK, March 11, 2022 /PRNewswire/ -- Terran Biosciences ("Terran"), a biotech platform company dedicated to the development of transformational therapeutics for โ€ฆSee details»

Concert Pharmaceuticals - Crunchbase Company Profile & Funding

Concert Pharmaceuticals is a clinical-stage biotechnology company dedicated to creating new medicines through a novel scientific approach utilizing the naturally-occurring element โ€ฆSee details»

Woodbridge Events Calendar for December 3, 2024 - Patch

NDC Holiday Concert. Dec 8, 2024. Holiday Bazaar . Dec 15, 2024. A Celtic Christmas + Add your event. Featured Classifieds + Add your classified. Latest News Nearby. Manassas Park, โ€ฆSee details»

Concert's CNS therapeutics - Updates, News, Events ... - Crunchbase

Organization. Concert's CNS therapeutics . Connect to CRM . Save . Summary People Signals & News Similar Companies. Recent News & Activity. Edit Recent News & Activity Section. โ€ฆSee details»

linkstock.net © 2022. All rights reserved